Disease | pleural effusion disorder |
Phenotype | C0278678|metastatic renal cell carcinoma |
Sentences | 1 |
PubMedID- 23328294 | Objective: to evaluate the safety and efficacy of sorafenib plus cisplatin in the treatment of metastatic renal cell carcinoma (mrcc) with pleural effusion. |
Page: 1